Avoro Capital Advisors LLC Ikena Oncology, Inc. Transaction History
Avoro Capital Advisors LLC
- $6.65 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding IKNA
# of Institutions
61Shares Held
33.2MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$7.23 Million1.36% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$6.87 Million0.26% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$5.89 Million2.33% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.59MShares$5.16 Million3.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.1 Million0.14% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $52.2M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...